Citius Pharmaceuticals (CTXR) Other Non Operating Income (2014 - 2024)
Citius Pharmaceuticals' (CTXR) quarterly Other Non Operating Income came in at $2.4 million in Q1 2024, down 33.41% on a QoQ basis from $3.6 million in Q4 2022.
Citius Pharmaceuticals (CTXR) Other Non Operating Income (2014 - 2024) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 7 years of Other Non Operating Income data on file, last reported at $2.4 million in Q1 2024.
- Quarterly Other Non Operating Income changed N/A year-over-year to $2.4 million in Q1 2024, while the trailing twelve-month figure through Sep 2024 was $2.4 million (down 33.41% YoY) and the FY2024 annual result came in at $2.4 million, down 33.41% from the prior year.
- Other Non Operating Income fell to $2.4 million in Q1 2024, from $3.6 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $3.6 million in Q4 2022 to a low of -$1.5 million in Q2 2021.
- A 3-year average of $1.5 million and a median of $2.4 million in 2024 frame the typical range for Other Non Operating Income.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.39 Mn |
| Dec 31, 2022 | 3.59 Mn |
| Jun 30, 2021 | -1.45 Mn |
| Mar 31, 2018 | 450,000.00 |
| Sep 30, 2016 | 93,000.00 |
| Jun 30, 2016 | 93,000.00 |
| Dec 31, 2015 | 87,000.00 |
| Sep 30, 2015 | 87,000.00 |
| Jun 30, 2015 | 87,000.00 |
| Mar 31, 2015 | 87,000.00 |
| Dec 31, 2014 | 87,000.00 |
| Sep 30, 2014 | 29,000.00 |